KdT Ventures
Edit

KdT Ventures

https://www.kdtvc.com
Last activity: 17.10.2024
Active
Invests in categories: PlatformHealthTechMaterialsTechnologyBioTechDrugMedtechProductDevelopmentEngineering
KdT Ventures is the standard for early-stage frontier science investing.
Portfolio
44
Persons
8
Mentions
22
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B
.

Portfolio 44

DateNameWebsiteTotal RaisedLocation
10.01.2024Perceptiveperceptive.io-United Sta...
19.07.2023SURGE Ther...surgetx.com$58M-
04.03.2023Elo Life S...elolife.com$20.5M-
04.03.2023Nosis Bionosisbio.com--
04.03.2023Syenexsyenex.com-United Sta...
04.03.2023Aperiam Bi...aperiambio.com$9MUnited Sta...
04.03.2023Charactercharacterbio.com$18MUnited Sta...
04.03.2023Cyberdonti...cyberdontics.io--
01.03.2023EQUIIequii.com$6MUnited Sta...
01.02.2023Dimension ...dimensioninx.com$15.18MUnited Sta...
Show more

Persons 8

DateFirst NameLast NameTitleLinkedInLocation
-KetanYerneniPrincipallinkedin.c...-
-PhilGrayeskiPartnerlinkedin.c...-
-YusufUddin, PhDHead of Ta...linkedin.c...-
-BlairWilletteSenior Fel...linkedin.c...-
-MackHealyPartnerlinkedin.c...-
-RimaChakrabart...Partnerlinkedin.c...-
-CainMcClary, M...Founder an...linkedin.c...-
-PatrickMalone, MD...Principallinkedin.c...-

Mentions in press and media 22

DateTitleDescription
17.10.2024KdT Ventures Closes Fourth Fund, at over $100MKdT Ventures, an Austin, Texas-based venture capital firm backing frontier science companies, closed its fourth fund, at over $100m. The fund, the firm’s largest fund to date, follows KdT’s previous $80 million Fund III which was announced ...
26.01.2024Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant DepressionWhat You Should Know: – Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from...
18.01.2022BREAKING: Faeth raises $20m from Khosla, AgFunder to battle cancer with foodDisclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics. Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V...
18.01.2022Faeth raises $20m from Khosla, AgFunder to battle cancer with foodDisclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics. Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V...
17.09.2021Debut Biotech is creating next-gen ingredients through ‘cell-free biomanufacturing’With climate change and its environmental consequences upon us, many companies are turning to more ‘natural’ alternatives to the chemical-based ingredients commonly used in food, beverages, cosmetics, and therapeutics. One such company is S...
16.09.202154gene Closes $25M Series B to Advance Global Drug Discovery Capabilities
14.09.2021BREAKING: Nitrogen fixer Andes scores $15m from Bayer, Wilbur-Ellis to move into carbon captureAndes, a Chilean-founded, US-based ag biotech startup, has raised $15 million in Series A funding. The round was co-led by the VC arms of Bayer and Wilbur-Ellis – Leaps by Bayer and Cavallo Ventures. Existing investors Endurance and KdT Ven...
14.09.2021Nitrogen fixer Andes scores $15m from Bayer, Wilbur-Ellis to move into carbon captureAndes, a Chilean-founded, US-based ag biotech startup, has raised $15 million in Series A funding. The round was co-led by the VC arms of Bayer and Wilbur-Ellis – Leaps by Bayer and Cavallo Ventures. Existing investors Endurance and KdT Ven...
12.08.2021Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing PlatformBy overcoming the limitations of cell-based fermentation, Debut Biotech produces high-value ingredients rapidly and more sustainably. SAN DIEGO (PRWEB) August 12, 2021 Debut Biotech, a next generation biomanufacturing platform harnessing ce...
28.03.2021KdT Ventures Raises $50 Million Fund to Invest in Early-Stage Science CompaniesAustin-based KdT Ventures announced a new $50 million fund to back early-stage science companies.
Show more

Reviews 0

Sign up to leave a review

Sign up Log In